Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study

Overview

Journal Cell

Publisher Cell Press

Specialty Cell Biology

Date 2020 Sep 26

PMID 32979319

Citations 26

Authors

Lewis Au

Laura Amanda Boos

Anthony Swerdlow

Fiona Byrne

Scott T C Shepherd

Annika Fendler

Samra Turajlic

Affiliations

Soon will be listed here.

Abstract

The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.

Citing Articles

Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.

Katsuya Y, Yoshida T, Takashima A, Yonemori K, Ohba A, Yazaki S Int J Clin Oncol. 2024; 29(4):386-397.

PMID: 38381163 PMC: 10963526. DOI: 10.1007/s10147-024-02470-x.

Targeting CD47 as a therapeutic strategy: A common bridge in the therapy of COVID-19-related cancers.

Zandi M, Shafaati M, Shenagari M, Naziri H Heliyon. 2023; 9(7):e17959.

PMID: 37456027 PMC: 10344805. DOI: 10.1016/j.heliyon.2023.e17959.

Efficacy and safety of COVID-19 vaccines for patients with spinal tumors receiving denosumab treatment: An initial real-clinical experience study.

Wang P, Li B, Zhou S, Xin Y, Zhu Z, Duan S Front Oncol. 2023; 13:1034466.

PMID: 37035168 PMC: 10073434. DOI: 10.3389/fonc.2023.1034466.

Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer.

Piening A, Ebert E, Khojandi N, Alspach E, Teague R Front Immunol. 2022; 13:1022732.

PMID: 36582225 PMC: 9792507. DOI: 10.3389/fimmu.2022.1022732.

Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy.

Hatic H, Hearld K, Das D, Deshane J Cancers (Basel). 2022; 14(23).

PMID: 36497435 PMC: 9735726. DOI: 10.3390/cancers14235954.

References

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R . Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020; 31(7):894-901. PMC: 7270947. DOI: 10.1016/j.annonc.2020.03.296. View

Lee L, Cazier J, Angelis V, Arnold R, Bisht V, Campton N . COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020; 395(10241):1919-1926. PMC: 7255715. DOI: 10.1016/S0140-6736(20)31173-9. View

Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Rydyznski Moderbacher C . Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020; 181(7):1489-1501.e15. PMC: 7237901. DOI: 10.1016/j.cell.2020.05.015. View

Rockett R, Arnott A, Lam C, Sadsad R, Timms V, Gray K . Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling. Nat Med. 2020; 26(9):1398-1404. DOI: 10.1038/s41591-020-1000-7. View

Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A . Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020; 10(7):935-941. PMC: 7334098. DOI: 10.1158/2159-8290.CD-20-0516. View

Luo J, Rizvi H, Egger J, Preeshagul I, Wolchok J, Hellmann M . Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers. Cancer Discov. 2020; 10(8):1121-1128. PMC: 7416461. DOI: 10.1158/2159-8290.CD-20-0596. View

Liang W, Guan W, Chen R, Wang W, Li J, Xu K . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3):335-337. PMC: 7159000. DOI: 10.1016/S1470-2045(20)30096-6. View

Garassino M, Whisenant J, Huang L, Trama A, Torri V, Agustoni F . COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020; 21(7):914-922. PMC: 7292610. DOI: 10.1016/S1470-2045(20)30314-4. View

Lara P, Burgos J, Macias D . Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 2020; 23:27-29. PMC: 7193092. DOI: 10.1016/j.ctro.2020.04.006. View

10.

Robilotti E, Babady N, Mead P, Rolling T, Perez-Johnston R, Bernardes M . Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020; 26(8):1218-1223. PMC: 7785283. DOI: 10.1038/s41591-020-0979-0. View

11.

Wei J, Luo C, Wang Y, Guo Y, Dai H, Tong C . PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity. J Immunother Cancer. 2019; 7(1):209. PMC: 6686487. DOI: 10.1186/s40425-019-0685-y. View

12.

Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z . Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020; 10(6):783-791. PMC: 7309152. DOI: 10.1158/2159-8290.CD-20-0422. View

13.

Solodky M, Galvez C, Russias B, Detourbet P, NGuyen-Bonin V, Herr A . Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19. Ann Oncol. 2020; 31(8):1087-1088. PMC: 7252166. DOI: 10.1016/j.annonc.2020.04.475. View

14.

Kuderer N, Choueiri T, Shah D, Shyr Y, Rubinstein S, Rivera D . Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020; 395(10241):1907-1918. PMC: 7255743. DOI: 10.1016/S0140-6736(20)31187-9. View

15.

Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano C . Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol. 2020; 31(8):1040-1045. PMC: 7202813. DOI: 10.1016/j.annonc.2020.04.479. View

16.

Luo J, Rizvi H, Preeshagul I, Egger J, Hoyos D, Bandlamudi C . COVID-19 in patients with lung cancer. Ann Oncol. 2020; 31(10):1386-1396. PMC: 7297689. DOI: 10.1016/j.annonc.2020.06.007. View

17.

. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020; 396(10243):27-38. PMC: 7259900. DOI: 10.1016/S0140-6736(20)31182-X. View